What is King Pharmaceuticals's all other lines — year 10?

King Pharmaceuticals (KG) reported all other lines — year 10 of -0.1% in Q4 2025.

What does all other lines — year 10 mean?

This metric tracks the financial performance of miscellaneous or non-core business segments during the tenth fiscal year. It captures the revenue and operational results of secondary activities that fall outside the primary reporting structure. This data is used to evaluate the contribution of peripheral business units to the company's long-term financial performance.

King Pharmaceuticals KG All other lines — Year 10

Other product segments

European Hospital Liability

4.9%—

General Liability

3.4%—

Commercial Auto Liability

0.9%—

International

-0.8%—

Similar metrics at other companies

SPNTOther — Year 10

0%—

SKWDMulti-line Solutions — Year 10

0.1%-1.1pp

ACGLMulti-line and other specialty — Year Ten

0.4%-1.0pp

SPNTOther Specialties — Year 10

0.1%—

SPNTOther — Year 9

0%—

UFCSPersonal — Year 10

0%—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's all other lines — year 10.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's all other lines — year 10?: King Pharmaceuticals (KG) reported all other lines — year 10 of -0.1% in Q4 2025.
What does all other lines — year 10 mean?: This metric tracks the financial performance of miscellaneous or non-core business segments during the tenth fiscal year. It captures the revenue and operational results of secondary activities that fall outside the primary reporting structure. This data is used to evaluate the contribution of peripheral business units to the company's long-term financial performance.